Broadlane

# High-Level Overview

Broadlane is a Dallas-based healthcare supply chain management and cost optimization company that provides strategic sourcing, capital equipment lifecycle management, medical device cost management, centralized procurement, and clinical consulting services to healthcare providers.[1] The company serves more than 1,100 acute care hospitals and 50,000 non-acute care providers, positioning itself as a major player in helping healthcare organizations reduce operating expenses while maintaining or improving quality of care.[1]

Broadlane's core mission centers on delivering end-to-end cost management capabilities for the healthcare industry. The company addresses a critical pain point in healthcare operations: the complexity and inefficiency of supply chain management and procurement across hospitals and health systems. By combining strategic sourcing expertise with clinical process optimization, Broadlane helps healthcare providers identify and capture significant cost savings opportunities.

# Origin Story

While the search results do not provide detailed founding information about Broadlane's origins, they indicate that the company was backed by TowerBrook Capital Partners, a middle-market private equity firm that invested in the company to reposition it for growth.[1] Under TowerBrook's ownership, Broadlane was repositioned to fulfill its growth potential and better serve the evolving needs of healthcare providers and suppliers.

The company's trajectory culminated in a major acquisition: MedAssets acquired Broadlane for approximately $850 million in cash, with the deal expected to close within three months of the announcement.[1] This acquisition represented a significant validation of Broadlane's market position and the value of its service offerings.

# Core Differentiators

• Comprehensive service portfolio: Beyond supply chain management, Broadlane offers clinical and lean process consulting and clinical workforce optimization—capabilities that extend beyond traditional procurement into operational improvement.[1]

• Scale and market reach: With relationships spanning 1,100+ acute care hospitals and 50,000 non-acute providers, Broadlane had established itself as one of the top four healthcare group purchasing organizations in the nation before its acquisition.[1]

• Proven financial impact: The combined entity with MedAssets reported non-GAAP adjusted EBITDA of nearly $162 million on combined net revenue of $509 million (as of 2009), with projected savings of $20 million in 2011 alone from operational synergies.[1][4]

• End-to-end integration: The acquisition by MedAssets created an integrated platform offering both supply chain optimization and broader financial improvement services, positioning the combined entity as a comprehensive cost management partner.[1]

# Role in the Broader Healthcare Landscape

Broadlane operates within the critical healthcare supply chain optimization sector, where cost pressures on hospitals and health systems create persistent demand for efficiency improvements. The company's focus on both procurement savings and clinical process optimization reflects a broader industry trend toward integrated financial and operational improvement—moving beyond simple cost-cutting to sustainable quality improvements.

The timing of Broadlane's growth and acquisition (circa 2010) coincided with heightened focus on healthcare cost containment following the 2008 financial crisis and in anticipation of healthcare reform. Hospitals faced mounting pressure to improve margins while maintaining care quality, making Broadlane's dual focus on cost and clinical outcomes particularly valuable.

By combining with MedAssets, Broadlane became part of a larger ecosystem addressing the full spectrum of healthcare financial management—from supply chain efficiency to revenue cycle optimization—reflecting the industry's shift toward comprehensive, data-driven cost management solutions.